The Cancer and Blood Disorders program at Arkansas Children’s Hospital (ACH) has received internationally recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT), designating the program as offering the highest quality patient care.
By demonstrating compliance with the FACT’s international standards, Arkansas Children’s Hospital has earned three-year accreditation for pediatric autologous hematopoietic progenitor cellular therapy and peripheral blood cellular therapy product collection.